| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/03/2013 | US8597654 Adjuvant therapy with an anti-ERBB2 antibody conjugated to a maytansiniod |
| 12/03/2013 | CA2489590C Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 12/03/2013 | CA2474497C Compositions and methods related to tim-3, a th1-specific cell surface molecule |
| 12/03/2013 | CA2463017C Method for preparation of single chain antibodies |
| 12/03/2013 | CA2213610C Ingap protein involved in pancreatic islet neogenesis |
| 11/28/2013 | WO2013176220A1 Regulation of circadian rhythm |
| 11/28/2013 | WO2013176054A1 Agent containing ascorbic acid derivative, and use for said agent |
| 11/28/2013 | WO2013174882A1 Composition for treating a circadian rhythm disorder |
| 11/28/2013 | WO2013173971A1 Use of fructus ligustri lucidi in the manufacture of a medicament for the prevention or treatment of a condition linked to weak bones in a young subject |
| 11/28/2013 | US20130318648 Diagnosis and therapeutic epitope, and transgenic plant |
| 11/28/2013 | US20130317216 2,4-pyrimidinediamine compounds and their uses |
| 11/28/2013 | US20130317047 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure |
| 11/28/2013 | US20130317013 Ep4 receptor agonist, compositions and methods thereof |
| 11/28/2013 | US20130317008 Use of a Specific Cyclic Amine Derivative or the Pharmaceutically Acceptable Salts Thereof for the Treatment or Prevention of Heart Failure |
| 11/28/2013 | US20130316999 Substituted oxazolidinones and their use in the field of blood coagulation |
| 11/28/2013 | US20130316990 Use of vitamin d compounds |
| 11/28/2013 | US20130316432 Inhibitors of extracellular proteases |
| 11/28/2013 | US20130315863 Methods and compositions for treating flaviviridae infections |
| 11/27/2013 | EP2666767A1 Therapeutic agent for TRPV1-mediated disease |
| 11/27/2013 | EP2665814A1 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells |
| 11/27/2013 | CN103415341A Copper-and-titanium-containing composition and production method therefor |
| 11/27/2013 | CN103405751A Composition with cell repairing function and preparation method and application thereof |
| 11/27/2013 | CN103405713A Sanhuang powder for preventing and treating swine heat stress in summer |
| 11/27/2013 | CN103405706A Traditional Chinese medicine formula for treating summer damp disease and preparation method thereof |
| 11/27/2013 | CN102574837B Novel 5-fluorouracil derivative |
| 11/26/2013 | US8592176 Methods for forming and using a stratified structure of epithelial cells |
| 11/26/2013 | US8592152 Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapy |
| 11/26/2013 | US8591897 Anti-ERBB2 antibody adjuvant therapy |
| 11/26/2013 | CA2378562C Method for producing oligopolysaccharides |
| 11/26/2013 | CA2279231C Activity dependent neurotrophic factor iii (adnf iii) |
| 11/21/2013 | WO2013172479A1 Carboxylic acid compounds |
| 11/21/2013 | WO2013172297A1 Preparation containing 6,7-unsaturated-7-carbamoylmorphinan derivative |
| 11/21/2013 | WO2013172087A1 Composition provided with nitric oxide production-inhibiting activity |
| 11/21/2013 | US20130312126 Methods and Compositions for RNAi Mediated Inhibition of Gene Expression in Mammals |
| 11/21/2013 | US20130310562 Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors |
| 11/21/2013 | US20130310388 Modulators of TNF-Alpha Signaling |
| 11/21/2013 | US20130310353 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 11/21/2013 | US20130310336 Methods and compositions for treating flaviviruses and pestiviruses |
| 11/21/2013 | US20130310320 Boronic ester and acid compounds, synthesis and uses |
| 11/21/2013 | US20130309303 Opiod Agonist Formulations with Releasable And Sequestered Antagonist |
| 11/21/2013 | US20130309289 Drug Delivery From Stents |
| 11/21/2013 | US20130309232 Vascular endothelial growth factor 2 |
| 11/20/2013 | EP2663366A1 Amino acid composition and its use for treating intrauterine foetal growth restriction (iugr) or for parenteral nutrition of extremely pre-term infants |
| 11/20/2013 | EP2663307A1 Anti-angiogenic compound |
| 11/20/2013 | EP2441760B1 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity |
| 11/20/2013 | EP2272869B1 Angiopoietin-2 specific binding agents |
| 11/20/2013 | EP2271621B1 Pyridyl derivatives as cftr modulators |
| 11/20/2013 | EP2251014B1 Combinations of an anti-cancer agent and a cholestanol derivative |
| 11/20/2013 | EP2246338B1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 11/20/2013 | EP2075334B1 EG-VEGF nucleic acids and polypeptides and methods of use |
| 11/20/2013 | EP1847244B1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 11/20/2013 | EP1801108B9 Morpholine compounds for the treatment of inflammations |
| 11/20/2013 | EP1683520B1 Water-soluble prodrugs |
| 11/20/2013 | CN103402995A Novel indole or indazole derivative or salt thereof |
| 11/20/2013 | CN103402993A Novel esters of 4,9-dihydroxy-naphtho[2,3-b]furans for disease therapies |
| 11/20/2013 | CN103402542A Medicinal agent for inhibiting metastasis of malignant tumor |
| 11/20/2013 | CN103402524A Concomitant drug for improving cognitive function |
| 11/20/2013 | CN103397052A Endothelial progenitor cell with highly-expressed human CXCR7 (C-X-C chemokine receptor 7) gene as well as preparation method and application of endothelial progenitor cell |
| 11/20/2013 | CN103396485A Method and composition for targeting polyubiquitin |
| 11/20/2013 | CN103394061A Externally-applied traditional Chinese medicine powder for treating hernia |
| 11/20/2013 | CN103393833A Traditional Chinese medicine electuary for treating children's night sweat and preparation method thereof |
| 11/20/2013 | CN103393820A Traditional Chinese medicine composite for treating hernia and preparation method thereof |
| 11/20/2013 | CN103393695A Methods and compositions for treatment and management of multiple myeloma |
| 11/20/2013 | CN103393681A Methodand composition for treatment and management of multiple myeloma |
| 11/20/2013 | CN103393643A Application of Sarcaboside A to monoamine oxidase inhibitor |
| 11/20/2013 | CN103393630A Method of inducing terminal differentiation |
| 11/20/2013 | CN103393607A Capsule formulation of pirfenidone and pharmaceutically acceptable excipients |
| 11/20/2013 | CN103393592A Sodium azulene sulfonate gel and its preparation method and use |
| 11/20/2013 | CN103393020A Method for preparing health-care honeyed pills by utilizing mung bean skins |
| 11/20/2013 | CN102655863B Heparanase activity inhibitor |
| 11/20/2013 | CN102100804B Snore relieving composite and preparation method thereof |
| 11/20/2013 | CN101703761B Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity |
| 11/20/2013 | CN101444621B Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (FGE) |
| 11/19/2013 | US8586762 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 11/19/2013 | US8586585 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease |
| 11/19/2013 | US8586538 Method of treating a patient suffering from a bleeding disorder comprising administering an antibody against the A3-C1 of FVIII |
| 11/19/2013 | US8586524 Modulators of pharmacological agents |
| 11/19/2013 | US8586332 Method for producing oligopolysaccharides |
| 11/19/2013 | US8586311 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| 11/19/2013 | US8586096 Soy or lentil stabilized gold nanoparticles and method for making same |
| 11/19/2013 | US8586088 Tamper-resistant oral opioid agonist formulations |
| 11/19/2013 | CA2613976C New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 11/19/2013 | CA2603030C Benzyloxypropylamine derivative |
| 11/19/2013 | CA2442684C Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 11/19/2013 | CA2404890C Rna sequence-specific mediators of rna interference |
| 11/19/2013 | CA2383217C Lysosomal targeting pathway enzymes |
| 11/19/2013 | CA2329757C Use of .alpha.1.beta.1 integrin receptor inhibitors and tgf-.beta.1 inhibitors in the treatment of kidney disease |
| 11/14/2013 | WO2013170189A1 Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow |
| 11/14/2013 | WO2013168760A1 Aromatic ring compound |
| 11/14/2013 | WO2013168759A1 Aromatic ring compound |
| 11/14/2013 | WO2013168694A1 Non-sugar energy-production-enhancing agent |
| 11/14/2013 | WO2013168455A1 Synergistic antidiabetic therapeutic agent |
| 11/14/2013 | WO2013168437A1 Organic compound nanopowder, production method therefor, and suspension |
| 11/14/2013 | WO2013168014A1 Compositions and methods for the treatment of familial amyloid polyneuropathy |
| 11/14/2013 | WO2013167991A1 Compositions and methods for the treatment of metabolic disorders |
| 11/14/2013 | US20130303790 Pseudopolymorphic Forms Of A HIV Protease Inhibitor |
| 11/14/2013 | US20130303586 Oligonucleotide compositions with enhanced efficiency |
| 11/14/2013 | US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase |
| 11/14/2013 | US20130303435 Smart Pro-Drugs of Serine Protease Inhibitors |
| 11/14/2013 | US20130302340 Human timp-1 antibodies |